Trial Profile
Multicentre, double-dummy, randomized, double-blind comparison between mitiglinide and nateglinide in the patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Mitiglinide (Primary) ; Nateglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 19 Aug 2009 Non-inferioirty results published in Journal of International Medical Research May-Jun 2009.
- 20 Oct 2008 Actual patient number (291) added as reported by ClinicalTrials.gov.
- 20 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.